BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND SMARCA4, hSNF2b, 6597, P51532, BRG1, SNF2L4, SNF2, SWI2, FLJ39786, BAF190, SNF2LB, SNF2-BETA, ENSG00000127616
84 results:

  • 1. A rare Ewing-like small round cell tumor in prostate: a case report and literature review.
    Wang Z; Ye J; Hu J; Zhang N; Yuan Y
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):110. PubMed ID: 38427070
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Whole-Genome Sequencing Analysis of Male breast cancer Unveils Novel Structural Events and Potential Therapeutic Targets.
    Al Assaad M; Michaud O; Semaan A; Sigouros M; Tranquille M; Phan A; Levine MF; Gundem G; Medina-Martínez JS; Papaemmanuil E; Manohar J; Wilkes D; Sboner A; Hoda SAF; Elemento O; Mosquera JM
    Mod Pathol; 2024 Apr; 37(4):100452. PubMed ID: 38369186
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Impact of Mutations in Subunit Genes of the Mammalian SWI/SNF Complex on Immunological Tumor Microenvironment.
    Hozumi C; Iizuka A; Ikeya T; Miyata H; Maeda C; Ashizawa T; Nagashima T; Urakami K; Shimoda Y; Ohshima K; Muramatsu K; Sugino T; Shiomi A; Ohde Y; Bando E; Furukawa K; Sugiura T; Mukaigawa T; Nishimura S; Hirashima Y; Mitsuya K; Yoshikawa S; Tsubosa Y; Katagiri H; Niwakawa M; Yamaguchi K; Kenmotsu H; Akiyama Y
    Cancer Genomics Proteomics; 2024; 21(1):88-101. PubMed ID: 38151294
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The impact of genomic context on outcomes of solid cancer patients treated with genotype-matched targeted therapies: a comprehensive review.
    Fulton-Ward T; Middleton G
    Ann Oncol; 2023 Dec; 34(12):1113-1130. PubMed ID: 37875224
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. In vivo CRISPR/Cas9 screening identifies Pbrm1 as a regulator of myeloid leukemia development in mice.
    Li BE; Li GY; Cai W; Zhu Q; Seruggia D; Fujiwara Y; Vakoc CR; Orkin SH
    Blood Adv; 2023 Sep; 7(18):5281-5293. PubMed ID: 37428871
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D-CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials.
    Zeverijn LJ; Looze EJ; Thavaneswaran S; van Berge Henegouwen JM; Simes RJ; Hoes LR; Sjoquist KM; van der Wijngaart H; Sebastian L; Geurts BS; Lee CK; de Wit GF; Espinoza D; Roepman P; Lin FP; Jansen AML; de Leng WWJ; van der Noort V; Leek LVM; de Vos FYFL; van Herpen CML; Gelderblom H; Verheul HMW; Thomas DM; Voest EE
    Int J Cancer; 2023 Oct; 153(7):1413-1422. PubMed ID: 37424386
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Pathogenic germline variants in smarca4 and further cancer predisposition genes in early onset ovarian cancer.
    Herold N; Schmolling J; Ernst C; Ataseven B; Blümcke B; Schömig-Markiefka B; Heikaus S; Göhring UJ; Engel C; Lampe B; Rhiem K; Harter P; Hauke J; Schmutzler RK; Hahnen E
    Cancer Med; 2023 Jul; 12(14):15256-15260. PubMed ID: 37345881
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. TGFB2-AS1 inhibits triple-negative breast cancer progression via interaction with smarca4 and regulating its targets
    Zhou C; Wang D; Li J; Wang Q; Wo L; Zhang X; Hu Z; Wang Z; Zhan M; He M; Hu G; Chen X; Shen K; Chen GQ; Zhao Q
    Proc Natl Acad Sci U S A; 2022 Sep; 119(39):e2117988119. PubMed ID: 36126099
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Redistribution of the SWI/SNF Complex Dictates Coordinated Transcriptional Control over Epithelial-Mesenchymal Transition of Normal breast Cells through TGF-β Signaling.
    Jdeed S; Lengyel M; Uray IP
    Cells; 2022 Aug; 11(17):. PubMed ID: 36078038
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. LINC00665 sponges miR-641 to promote the progression of breast cancer by targeting the snf2-related CREBBP activator protein (SRCAP).
    Cao W; Liu X; Su W; Liang H; Tang H; Zhang W; Huang S; Dang N; Qiao A
    Bioengineered; 2022 Feb; 13(2):4573-4586. PubMed ID: 35152838
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. FGFR-inhibitor-mediated dismissal of SWI/SNF complexes from YAP-dependent enhancers induces adaptive therapeutic resistance.
    Li Y; Qiu X; Wang X; Liu H; Geck RC; Tewari AK; Xiao T; Font-Tello A; Lim K; Jones KL; Morrow M; Vadhi R; Kao PL; Jaber A; Yerrum S; Xie Y; Chow KH; Cejas P; Nguyen QD; Long HW; Liu XS; Toker A; Brown M
    Nat Cell Biol; 2021 Nov; 23(11):1187-1198. PubMed ID: 34737445
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. BAF57 Is a Potential Determinant of Colorectal cancer Malignancy.
    Suzumura H; Tsuruta M; Okabayashi K; Shigeta K; Seishima R; Ishida T; Shimada T; Asada Y; Koishikawa K; Akimoto S; Itano O; Hasegawa H; Kitagawa Y
    Anticancer Res; 2021 Nov; 41(11):5445-5452. PubMed ID: 34732413
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A Pan-cancer Analysis of smarca4 Alterations in Human cancers.
    Peng L; Li J; Wu J; Xu B; Wang Z; Giamas G; Stebbing J; Yu Z
    Front Immunol; 2021; 12():762598. PubMed ID: 34675941
    [TBL] [Abstract] [Full Text] [Related]  

  • 14.
    Mardinian K; Adashek JJ; Botta GP; Kato S; Kurzrock R
    Mol Cancer Ther; 2021 Dec; 20(12):2341-2351. PubMed ID: 34642211
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Histologic and genomic features of breast cancers with alterations affecting the SWI/SNF (SMARC) genes.
    Schwartz CJ; Pareja F; da Silva EM; Selenica P; Ross DS; Weigelt B; Brogi E; Reis-Filho JS; Wen HY
    Mod Pathol; 2021 Oct; 34(10):1850-1859. PubMed ID: 34079072
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Zinc finger protein E4F1 cooperates with PARP-1 and brg1 to promote DNA double-strand break repair.
    Moison C; Chagraoui J; Caron MC; Gagné JP; Coulombe Y; Poirier GG; Masson JY; Sauvageau G
    Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33692124
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Distinct roles of BRCA2 in replication fork protection in response to hydroxyurea and DNA interstrand cross-links.
    Rickman KA; Noonan RJ; Lach FP; Sridhar S; Wang AT; Abhyankar A; Huang A; Kelly M; Auerbach AD; Smogorzewska A
    Genes Dev; 2020 Jun; 34(11-12):832-846. PubMed ID: 32354836
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Next-generation sequencing identifies recurrent copy number variations in invasive breast carcinomas from Ghana.
    Anwar T; Rufail ML; Djomehri SI; Gonzalez ME; Lazo de la Vega L; Tomlins SA; Newman LA; Kleer CG
    Mod Pathol; 2020 Aug; 33(8):1537-1545. PubMed ID: 32152520
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Zinc finger protein 367 promotes metastasis by inhibiting the Hippo pathway in breast cancer.
    Wu X; Zhang X; Yu L; Zhang C; Ye L; Ren D; Li Y; Sun X; Yu L; Ouyang Y; Chen X; Song L; Liu P; Lin X
    Oncogene; 2020 Mar; 39(12):2568-2582. PubMed ID: 31988454
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. RAD54B potentiates tumor growth and predicts poor prognosis of patients with luminal A breast cancer.
    Zhang Z; Li X; Han Y; Ji T; Huang X; Gao Q; Ma D
    Biomed Pharmacother; 2019 Oct; 118():109341. PubMed ID: 31545289
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.